SEC Form 4 · accession 0001354488-16-005954
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew K Chan
Other
Period of report
Jan 19, 2016
Accepted (ET)
Jan 21, 2016 · 9:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 19, 2016 | M | 1,516 | $5.61 | A | 147,273 | D | |
| Common StockF2 | Jan 19, 2016 | S | 1,516 | $12.07 | D | 145,757 | D | |
| Common StockF2 | Jan 21, 2016 | M | 1,296 | $3.00 | A | 147,053 | D | |
| Common StockF2 | Jan 21, 2016 | S | 1,296 | $13.87 | D | 145,747 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non- Qualified Stock Option (right to buy) (2013 Plan)F2,F3 | $5.61 | Jan 19, 2016 | M | 1,516 | D | — | May 16, 2023 | Common Stock | 1,516 | 39,420 | D |
| Non- Qualified Stock Option (right to buy) (2011 Plan)F2,F4 | $3.00 | Jan 21, 2016 | M | 1,296 | D | — | Feb 20, 2023 | Common Stock | 1,296 | 40,187 | D |
Explanation of responses
- F1The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- F2On December 22, 2015, due to miscommunications with regard to the nature of transactions undertaken by the reporting person in September 2015, the reporting person mistakenly reported the number of shares of common stock and derivative securities of the issuer owned by him after certain transactions undertaken in December 2015. As a result, the number of outstanding securities owned by the reporting person after each transaction as reported on this form reflects corrections of the reporting errors made in December 2015.
- F3The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.
- F4The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.